F S&P 500
5,243.75 +4.75 (+0.09%) F Dow Jones
39,585.00 +49.00 (+0.12%) F Nasdaq
18,227.50 +13.00 (+0.07%) E-mini Russell 2000 Index Futur
2,086.00 +1.90 (+0.09%) Petróleo
79.63 +0.37 (+0.47%) Oro
2,354.30 +14.00 (+0.60%)
Orthocell Limited (OCC.AX)
Orthocell Limited
Building 191
Murdoch University 90 South Street
Murdoch, WA 6150
Australia
61 8 9360 2888
https://orthocell.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Paul Frederick Anderson | CEO, MD & Executive Director | 650.97k | N/D | 1966 |
| Ms. Nicole Jane Telford | Chief Financial Officer | N/D | N/D | N/D |
| Mr. Alex McHenry | Chief Operating Officer | N/D | N/D | N/D |
| Prof. Ming Hao Zheng | Chief Scientific Officer and Member of Medical & Scientific Advisory Board | N/D | N/D | N/D |
| Mr. Tony Macintyre | Chief Technical Operations Officer | N/D | N/D | N/D |
| Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D. | Company Secretary | N/D | N/D | 1963 |
Descripción
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.
Gestión corporativa
La calificación ISS Governance QuickScore de Orthocell Limited a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
